Company Overview:

Avalyn Pharma is developing innovative, targeted inhaled therapies for rare respiratory diseases, including idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). Avalyn completed an oversubscribed $175M Series C financing in September 2023 to advance our clinical-stage pulmonary fibrosis portfolio consisting of inhaled pirfenidone (AP01), inhaled nintedanib (AP02), and a fixed-dose combination of both (AP03). Currently, treatment for IPF and PPF includes oral antifibrotics, pirfenidone and nintedanib. Due to side effects, 30-50% of patients cannot tolerate these medications. Avalyn has developed inhaled formulations for these FDA-approved antifibrotics. AP01 has now been studied in over 150 patients with various forms of pulmonary fibrosis, over at least 48 weeks and some out to 4 years and is phase 2b ready. PK studies show that AP01 reaches thirty-five times the concentration in the lung with 1/15th of the systemic concentration compared to historic oral pirfenidone. AP01 has demonstrated efficacy, with a high dose achieving near stabilization of lung function and is well tolerated with fewer systemic adverse events vs. historic oral pirfenidone. We have also completed our a phase 1a study of AP02, an inhaled formulation of nintedanib, with phase 1b & 2 plans being developed. Phase 1a positive topline results were announced in March 2023, and AP02 was demonstrated to be safe and well tolerated in normal volunteers & IPF patients.

Position Overview:

As a Senior Manager of Corporate Development, you will play a pivotal role in supporting and enhancing the company’s corporate narrative, investor engagement, and communications efforts. This high visibility role involves direct interaction with executive leadership. You will be responsible for managing investor interactions and driving awareness of our clinical and corporate milestones across key stakeholders, including investors, analysts, media, and the broader biotech community. At Avalyn, you will have the opportunity to directly influence key decisions, helping us achieve our mission of delivering life-changing therapies for patients with unmet needs. You will report to the Director of Corporate Development.

Key Responsibilities:

Investor Relations (IR): 70%

• Maintain investor and banking contact databases, investor interaction notes, and
• Serve as the primary internal contact for investor inquiries, coordinating cross-functional responses to diligence questions.
• Monitor, analyze, and report on equity performance, including market trends and shareholder value impact, and provide insights to senior leadership.
• Plan and execute investor conferences, roadshows, and non-deal roadshows, managing logistics and follow-ups.
• Support the development of earnings materials, investor presentations, Q&A documents, and call scripts. Track and assist with CDA management and maintain virtual data rooms.
• Synthesize analyst reports and compile analyst models to formulate internal view of analyst consensus.
• Assist in shaping and executing the investor relations strategy to communicate corporate developments, financial performance, and clinical progress.
• Conduct peer benchmarking to refine messaging and positioning.

Public Relations (PR) and Corporate Communications: 20%

• Draft and review press releases, corporate presentations, website content, and other external communications materials.
• Coordinate with external agencies on digital media initiatives, including the development of social media content, to ensure all messaging aligns with the company’s overarching narrative and objectives.
• Manage the company’s presence across digital platforms, including website updates and social media strategy.
• Collaborate cross-functionally with clinical, nonclinical, medical affairs, and commercial teams to ensure consistent and accurate messaging across all external communications.
• Manage media relations efforts, including developing key messages, coordinating interviews, and monitoring media coverage.
• Lead the development of internal and external communications plans.

Other (Competitive Intelligence, Business Development): 10%

• Support competitive intelligence initiatives, tracking upcoming milestones, M&A, partnerships, and data readouts in collaboration with Medical Affairs
• Support business development and pre-commercial initiatives, including but not limited to new product planning, life cycle management, commercial assessment, and market access.

Key requirements for this role are:

• Bachelor’s degree in life sciences, public health, business, communications, or a related field (advanced degree preferred).
• 5-7 years of experience in strategy consulting, private/public equity investing, investment banking, corporate development, investor relations, corporate communications, and/or related functions in the biotech or pharmaceutical industries, preferably in late-stage private biotech or publicly traded biotech companies.
• Experience managing clinical data communications, financial disclosures, and executive visibility.
• Advanced proficiency in Microsoft Excel and PowerPoint is a must, with experience in financial modeling, data analysis, developing investor decks, press releases, and social media content.
• Preferred experience with investor relations and CRM platforms such as Salesforce, Q4, Nasdaq IR Insight, IHS Markit, Affinity, Bloomberg Terminal, FactSet, OpenExchange, and Mailchimp.
• Strong understanding of biotech capital markets, investor sentiment, and financial communication.
• Excellent written and verbal communication skills, with the ability to translate complex scientific and financial information into clear, compelling messages.
• Experience working cross-functionally with internal stakeholders including clinical and nonclinical teams, medical affairs, communications/corporate affairs and HR.
• High attention to detail, strategic thinking, and a collaborative mindset.
• Ability to manage multiple projects in a fast-paced environment with a drive for results and sense of urgency to meet medical market needs.
• Willingness to travel, conferences, and meetings as needed.
• Self-motivated, independent, and able to work effectively in a small team and fast-paced environment.

Strong organizational and time-management skills, with the ability to prioritize and manage multiple projects simultaneously